We are live on
!
Find out more
Janux Therapeutics
JANX
JANX
216 hedge funds and large institutions have $3.43B invested in Janux Therapeutics in 2024 Q4 according to their latest regulatory filings, with 78 funds opening new positions, 80 increasing their positions, 43 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
271% more first-time investments, than exits
New positions opened: 78 | Existing positions closed: 21
233% more funds holding in top 10
Funds holding in top 10: 3 → 10 (+7)
91% more call options, than puts
Call options by funds: $37.7M | Put options by funds: $19.7M
86% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 43
66% more capital invested
Capital invested by funds: $2.07B → $3.43B (+$1.36B)
35% more funds holding
Funds holding: 160 → 216 (+56)
23.5% more ownership
Funds ownership: 87.46% → 110.97% (+24%)
Holders
216
Holders Change
+56
Holders Change %
+35%
% of All Funds
2.85%
Holding in Top 10
10
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+233.33%
% of All Funds
0.13%
New
78
Increased
80
Reduced
43
Closed
21
Calls
$37.7M
Puts
$19.7M
Net Calls
+$18M
Net Calls Change
+$43.7M
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$26.4M |
| 2 |
VPC
Vestal Point Capital
New York
|
-$22M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$6.23M |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$4.95M |
| 5 |
State Street
Boston,
Massachusetts
|
-$4.93M |
